Compare · CHE vs PIII
CHE vs PIII
Side-by-side comparison of Chemed Corp (CHE) and P3 Health Partners Inc. (PIII): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CHE and PIII operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- CHE is the larger of the two at $5.86B, about 69.9x PIII ($83.9M).
- Over the past year, CHE is down 19.5% and PIII is up 65.9% - PIII leads by 85.4 points.
- CHE has been more active in the news (10 items in the past 4 weeks vs 2 for PIII).
- CHE has more recent analyst coverage (6 ratings vs 5 for PIII).
- Company
- Chemed Corp
- P3 Health Partners Inc.
- Price
- $441.85+2.25%
- $11.24+13.53%
- Market cap
- $5.86B
- $83.9M
- 1M return
- +4.11%
- +291.13%
- 1Y return
- -19.54%
- +65.86%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NYSE
- NASDAQ
- IPO
- 2021
- News (4w)
- 10
- 2
- Recent ratings
- 6
- 5
Chemed Corp
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates in two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned branches and independent contractors, and franchised locations. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
P3 Health Partners Inc.
P3 Health Partners Inc. provides primary health care services. The company offers clinical operations and population health management services, as well as provides senior wellness centers. The company is based in Henderson, Nevada.
Latest CHE
- Director Walsh George J Iii sold $218,915 worth of Capital Stock (500 units at $437.83), decreasing direct ownership by 13% to 3,209 units (SEC Form 4)
- Chemed Corp filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Walsh George J Iii was granted 386 units of Capital Stock, increasing direct ownership by 12% to 3,709 units (SEC Form 4)
- Director Mount John Meredith Jr. was granted 386 units of Capital Stock, increasing direct ownership by 42% to 1,316 units (SEC Form 4)
- Director Mccarthy Eileen P was granted 386 units of Capital Stock, increasing direct ownership by 45% to 1,241 units (SEC Form 4)
- Director Lindell Andrea R was granted 386 units of Capital Stock, increasing direct ownership by 7% to 5,925 units (SEC Form 4)
- Director Heaney Christopher J was granted 386 units of Capital Stock, increasing direct ownership by 16% to 2,775 units (SEC Form 4)
- Director Grace Patrick P was granted 386 units of Capital Stock, increasing direct ownership by 12% to 3,723 units (SEC Form 4)
- Director Delyons Ron was granted 386 units of Capital Stock, increasing direct ownership by 23% to 2,052 units (SEC Form 4)
- Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend
Latest PIII
- P3 Health Partners Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits
- SEC Form 4 filed by Chief Financial Officer Pedersen Leif Elliott
- P3 Health Partners Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits
- SEC Form 10-Q filed by P3 Health Partners Inc.
- P3 Health Partners Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- P3 Health Partners Announces First Quarter 2026 Results
- SEC Form DEFA14A filed by P3 Health Partners Inc.
- SEC Form DEF 14A filed by P3 Health Partners Inc.
- P3 Health Partners Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
- SEC Form PRE 14A filed by P3 Health Partners Inc.